Warning letter · FDA Warning Letters

Plantacea, LLC dba Kahm: FDA Warning Letter 623508 (May 26, 2022)

Agency action: May 26, 2022Record ID: fda_warning_-c6a5526e26a99cf5
View official source ↗

What happened

Original notice title

Plantacea, LLC dba Kahm MARCS-CMS 623508, May 26, 2022

From the archived source record

The claims on your website and social media websites establish that your products “CBD Hemp Pellets” and “K9 Soft Chews,” which you promote as products containing CBD for use in animals, are unapproved new animal drugs that are unsafe under section 512(a) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 360b(a), and adulterated under section 501(a)(5) of the FD&C Act, 21 U.S.C. 351(a)(5). In addition, your CBD products for human use, “Kahm EQUIPASS RELIEF GEL,” “Kahm CBD MUSCLE FREEZE ROLL ON,” “Kahm BODY CREAM,” “Kahm CBD BROAD SPECTRUM HEMP EXTRACT” (all varieties), and “Kahm CBD NANO CBD SALVE” (hereinafter “Kahm CBD products for humans”), as well as your “Tanka 30 day CBD Band,” “Tanka T-FLEX Band” and “Tanka Collagen Band,” with respect to their ingredients intended for delivery through the skin (hereinafter “Tanka products for humans”), are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d). Furthermore, your Kahm CBD products for humans and Tanka products for humans are misbranded drugs under section 502(f)(1) of the FD&C Act, 21 U.S.C. 352(f)(1). FDA has also determined that your CBD Gummies products in Blue Raspberry and Raspberry flavors are adulterated under section 402(a)(2)(C)(i) of the FD&C Act, 21 U.S.C. 342(a)(2)(C)(i), because they bear or contain an unsafe food additive. The Agency is particularly concerned that you market CBD products for food-producing animals. In addition to raising potential concerns regarding safety for the animals themselves, CBD products for food-producing animals raise concerns regarding the safety of the human food (meat, milk, and eggs) derived from those animals. We request that you take immediate action to cease the sale of any unapproved CBD products for food-producing animals.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
No closeout listed in FDA table
Source checked
Jul 16, 2026
Record revision
9d352ba0ccc8

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
CBD Hemp Pellets; K9 Soft Chews; Kahm EQUIPASS RELIEF GEL; Kahm CBD MUSCLE FREEZE ROLL ON; Kahm CBD BROAD SPECTRUM HEMP EXTRACT; Kahm CBD NANO CBD SALVE; Kahm CBD products for humans; Tanka 30 day CBD Band; Tanka T-FLEX Band; FOR EQUINE & LIVESTOCK; Broad-Spectrum Hemp Pellets; Tanka Collagen Band; • From your “Kahm EQUIPASS RELIEF GEL; Effective for:  Muscle Mass  Arthritis  Skin Elasticity; Broad Spectrum Hemp Extract; CBD Tincture (Oil); Suite 140 Las Vegas; NV 89148 United States orders@kahmcbd; Kahm CBD BROAD SPECTRUM HEMP EXTRACT products (all varieties) as dietary supplements
Company
Plantacea, LLC dba Kahm
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.